There is accumulating evidence that local reninangiotensin systems (RASs) influence cell growth and organ function in a variety of tissues including the ovary. The first aim of this study was to characterise the cellular location of RAS components in the rat ovary. This was facilitated by the use of the hypertensive transgenic (mRen-2)27 rat which overexpresses renin and angiotensin in extra-renal tissues. Comparisons were made with normal Sprague-Dawley (SD) rats. The second aim was to determine if the upregulated RAS of the transgenic (mRen-2)27 rat and infusion of angiotensin II (ANG II) in SD rats influences follicle number and litter size. Gene expression, immunohistochemical and autoradiographic techniques were used to identify a discrete RAS including ANG II receptors in the ovarian stroma, follicles (particularly atretic) and to a lesser extent corpora lutea. The RAS at these sites was most abundant in homozygous (HMZ) followed by heterozygous (HTZ) (mRen-2)27 rats and then SD rats. Large antral and preovulatory follicles and litter size were reduced in (mRen-2)27 rats. In HMZ (mRen-2)27 rats and SD rats infused with ANG II, angiotensin 1a (AT 1a ) receptor mRNA in the ovarian stroma was lower than control SD rats and was associated with a reduction in large antral and preovulatory follicles. These findings indicate that upregulation of the ovarian RAS in the rat influences follicular development and, potentially, reproductive capacity.
Introduction
Apart from its role in the regulation of blood pressure and fluid homeostasis, angiotensin II (ANG II) also influences cell growth, angiogenesis and programmed cell death (Fernandez et al. 1985 , Daemen et al. 1991 , Moravski et al. 2000 . The cellular effects of ANG II may occur via local production in tissues, as reninangiotensin systems (RASs) have been identified in many organs including the eye (Berka et al. 1995) , adrenal (Ryan 1967 , Berka et al. 1996 , heart (Bohm et al. 1995) and thymus . There is also considerable evidence for the existence of local RASs in reproductive tissues such as the uterus (Ryan & Johnson 1969) , testis (Pandey et al. 1984) and placenta (Hodari et al. 1967 , Skinner et al. 1968 . With regard to the ovary, components of the RAS have been identified in many species, and locally produced ANG II has been suggested to have diverse roles including the modulation of atresia, steroidogenesis, ovulation, oocyte maturation, corpus luteum formation and angiogenesis (Yoshimura 1997 , Speth et al. 1999 , Vinson et al. 1999 . However, some of the actions of ANG II appear contradictory, and as the distribution, abundance and role of the ovarian RAS varies between species, further investigation into the ovarian RAS is justified.
While studies of the rat ovary have provided information regarding the local effects of ANG II (Yoshimura 1997 , Speth et al. 1999 , Vinson et al. 1999 , the characterisation of the rat ovarian RAS has to some extent been limited by the low levels of tissue RAS expression (Phillips et al. 1993) . The normal Sprague-Dawley (SD) rat possesses the Ren-1 gene which is responsible for the expression of renin in kidney and low levels of renin in extra-renal tissues (Ekker et al. 1989) . To study the role of extra-renal RASs in the development of hypertension, the transgenic (mRen-2)27 rat was developed by the introduction of the murine Ren-2 gene into the genome of the SD rat (Mullins et al. 1990 ). The hypertensive transgenic (mRen-2)27 rat exhibits amplified circulating prorenin, extra-renal renin and angiotensin at sites where they would normally be expressed in low amounts in the SD rat. This feature has allowed the distribution and function of tissue RASs to be studied in both normal and disease states (Bohm et al. 1995 , Kelly et al. 1998 , Moravski et al. 2000 .
The first aim of the present study was to determine the cellular location of the RAS in the rat ovary.
The transgenic (mRen-2)27 rat was compared with the normal SD rat. To facilitate identification of the ovarian RAS, (mRen-2)27 rats homozygous (HMZ) for the Ren-2 gene were compared with their heterozygous (HTZ) counterparts. HMZ (mRen-2)27 rats have previously been reported to exhibit higher levels of extrarenal renin and angiotensin and blood pressure than HTZ (mRen-2)27 rats (Bader et al. 1992) . The second aim was to determine if amplification of the RAS in the transgenic (mRen-2)27 rat and infusion of ANG II in SD rats influences follicular development and litter size.
Materials and Methods

Animals
All experimental procedures adhered to the guidelines of the National Health and Medical Research Council of Australia's Code for the Care and Use of Animals for Scientific Purposes, and were approved by the Bioethics Committee of the University of Melbourne. All rats were housed in a stable environment (maintained at 20 2 C with a 12 h light:12 h darkness cycle) and allowed free access to tap water and standard rat chow (GR2, Clark-King & Co., New South Wales, Australia). All rats were between 13 and 16 weeks old and a sample size of 6-8 rats per group was used for each of the parameters analysed.
Four groups of rats were studied: group 1, transgenic (mRen-2)27 rats HMZ for the Ren-2 gene; group 2, transgenic (mRen-2)27 rats HTZ for the Ren-2 gene; group 3, control SD rats; and group 4, SD rats infused with ANG II for 12-14 days (SD+ANG II). Transgenic (mRen-2)27 rats HMZ for the Ren-2 gene usually require anti-hypertensive therapy for survival; this was withdrawn from breeding pairs and throughout the entire study. HTZ (mRen-2)27 rats were derived by mating a HMZ male (mRen-2)27 rat with a female SD rat and do not require anti-hypertensive therapy for survival. Transgenic (mRen-2)27 rats were obtained from our breeding colony established in 1996 and SD rats were obtained from the Animal Research Centre (ARC, Canning Vale, Perth, Western Australia, Australia).
In group 4, SD rats were anaesthetised with a mixture of 0·5 mg/kg medetomidine (Domitor; Novartis Pharma AG, Basel, Switzerland) and 75 mg/kg ketamine hydrochloride (Ketalar, Parke Davis Pty Ltd, Auckland, New Zealand). A small area of skin at the back of the neck was shaved and Riodine Povidone-Iodine antiseptic solution (Orion Laboratories Pty Ltd, Western Australia, Australia) was liberally applied to the area. A 0·5 cm incision was made and the skin separated from the superficial fascia by blunt dissection. A mini-osmotic pump (Alzet model 2004, Alza Corporation, Palo Alto, CA, USA) was inserted subcutaneously into a prepared area and the incision closed with several small sutures. Metetomidine anaesthesia was reversed using 1 mg/kg atipamezole hydrochloride (Antisedan; Novartis). The mini-osmotic pumps were filled with 10·4 mg/ml ANG II dissolved in 0·9% NaCl, using a 26-gauge needle attached to a 1 ml syringe. Pumps were weighed prior to and after filling to ensure maximum capacity was reached. Mean pump capacity was 99 4·5 µl and the mean pumping rate was 0·21 0·01 µl/h. Based on an average rat body weight of 250 g, the delivery rate of ANG II was calculated as 145 ng/kg per min.
Oestrus cycle
To ensure that the stage of oestrus cycle did not influence the interpretation of results, ovaries were collected at proestrus for in situ hybridisation, immunohistochemistry, renin assay and ANG II receptor and angiotensinconverting enzyme (ACE) autoradiography. Systolic blood pressure (SBP) was measured at proestrus. Oestrus cycle was evaluated by daily histological examination (between 0900 and 1200 h) of the vaginal epithelium. Smears obtained by vaginal lavage were stained with Giemsa's stain No. 11 (BDH, Poole, Dorset, UK) and were identified by light microscopy as: proestrus (day 1), oestrus (day 2), diestrus (day 3) or pre-proestrus (day 4). To ensure that the stage of the oestrus cycle did not influence the ovarian and plasma RAS, all rats were killed at the same time of day (1300-1700 h).
Systolic blood pressure
SBP was recorded prior to tissue collection in pre-warmed conscious rats by tail cuff plethysmography. Arterial pressure changes detected by a Pneumatic Pulse Transducer PE-300 (Narco Biosystems Inc., TX, USA) were recorded using a Chart program (version 3·5) on a Maclab/2E System (AD Instruments Pty Ltd, Australia). SBP was taken at the same time of the day (1400-1700 h) in order to minimise circadian influences from an average of at least three consecutive measurements (Bunag 1973) .
The cellular localisation of the ovarian RAS in untreated HTZ and HMZ (mRen-2)27 rats and control SD rats
In situ hybridisation for renin and ANG II receptors At proestrus, (mRen-2)27 and SD rats were anaesthetised with an intraperitoneal injection of pentobarbital sodium (Nembutal, 50 mg/kg body weight, Boehringer Ingelheim, Australia) and a midline incision made. Ovaries were removed and cleaned of adherent adipose tissue. One ovary was collected from each rat and immersed in Bouins fixative (Pathtec Diagnostics Pty Ltd, Victoria, Australia), routinely processed and embedded in paraffin. Each ovary was serially sectioned at 3 µm and placed on 1% 3-aminopropyltriethoxysilane-coated slides.
Six randomly chosen sections from one ovary from each rat (n=6rats per group) were hybridised with [ 33 P]UTPlabelled riboprobes as previously described (Moravski et al. 2000) . Riboprobes were prepared from: cDNA encoding mouse renin (0·525 kbp; gift of Dr D J Campbell, St Vincent's Institute of Medical Research, Melbourne, Australia) cloned into pGEM3Z plasmid (Promega) and linearised with HindIII to produce antisense riboprobe using T7 RNA polymerase. pBluescript II KS plasmids (Stratagene, La Jolla, CA, USA) containing cDNA encoding rat AT 1a (2·3 kbp) or AT 2 (1·15 kbp) (gift of Dr A Allen, Howard Florey Institute, Melbourne, Australia), were linearised with HpaI (AT 1a ) or BamHI (AT 2 ), and antisense riboprobes transcribed using the RNA polymerases T3 and T7 respectively. After washing to remove unbound probe, sections were exposed to Kodak BioMax autoradiograph film (Kodak) for 7 days. Densitometric analysis of the autoradiographic signal was performed by scanning autoradiograph images using a flat-bed scanner attached to an IBM computer with a 512 512 pixel array imaging board with 256 grey levels (Moravski et al. 2000) . Quantitative measures of the density of digitised autoradiographs were evaluated using an appropriately calibrated Analytical Imaging Station (AIS; Imaging Research, Ontario, Canada). The density of labelling over the area of the entire ovary was quantified as an index of gene expression, and data expressed as relative optical densities (ROD). All analyses were done with the observer masked to the animal study group. To determine the cellular localisation of hybridisation signal, slides were subsequently coated in 50% LM-1 Amersham Hypercoat liquid emulsion (Amersham) for 28 days, developed, and counterstained with haematoxylin and eosin (Amber Scientific Pty Ltd, Belmont, Western Australia, Australia).
Immunohistochemistry for RAS components Using established methods (Berka et al. 1995 , randomly chosen 3 µm paraffin sections of ovary were incubated with either a polyclonal rabbit anti-rat angiotensinogen antiserum (gift of Dr Conrad Sernia, Department of Physiology and Pharmacology, University of Queensland, Australia) (Sernia et al. 1986 ), a polyclonal rabbit anti-rat renin antiserum (gift of Dr Joël Ménard, INSERM U367, Paris, France) or a polyclonal guinea-pig anti-human ANG II primary antisera (Peninsula Laboratories Inc., Belmont, CA, USA). Following thorough washing with 0·1 M PBS, the sections were incubated with either biotinylated goat anti-rabbit immunoglobulin (for angiotensinogen; Dako Corporation, Carpinteria, California, USA), biotinylated rat anti-rabbit immunoglobulin (for renin; Dako Corporation), or biotinylated goat anti-guinea-pig immunoglobulin (for ANG II; Pierce, Rockford, IL, USA), diluted 1:200 with PBS. To visualise the location of protein immunolabelling, sections incubated with a pre-formed avidin and biotinylated horseradish peroxidase macromolecular complex (diluted 1:200 with 0·1 M PBS; Vectastain Elite ABC Kit, Vector Laboratories Inc., Burlingame, CA, USA) for 30 min, and reacted with 3,3 -diaminobenzidine chromagen solution (DAB; Dako Corporation) diluted in imidazole-HCl buffer (containing hydrogen peroxide, pH 7·5). Sections were counterstained with Mayer's haematoxylin. Sections incubated with normal serum instead of the primary antibody served as negative controls. Positive controls were liver for angiotensinogen, and juxtaglomerular cells in kidney for renin and ANG II (not shown).
Angiotensin-converting enzyme (ACE) autoradiography One ovary was collected from each rat and embedded using TissueTek OCT embedding compound (Sakura Finetek USA Inc., Torrance, CA, USA) in 25 mm 20 mm 5 mm TissueTek cryomoulds (Miles Inc. Diagnostics Division, Elkhart, IN, USA); ovaries were rapidly frozen by placing them on dry ice. Iodinated MK-351A, a potent competitive inhibitor of ACE, was used to facilitate the autoradiographic localisation of ACE in 20 µm frozen sections according to the methodology of Mendelsohn et al. (Mendelsohn 1984) . Non-specific binding in parallel sections was assessed in the presence of 125 I-labelled MK-351A and 1 mM EDTA (BDH Laboratory Supplies, Poole, UK) which contains zinc residues that bind to the active site of ACE. Sections of rat lung served as positive controls. Tissue sections were washed, dried and exposed to Kodak BioMax autoradiograph film. Densitometric analysis of autoradiographic binding was performed and quantitated as described above for in situ hybridisation. In order to visualise anatomical localisation of binding, sections were first post-fixed overnight in a sealed container with paraformaldehyde powder (BDH), before slides were coated in liquid emulsion for 7 days, developed and counterstained with haematoxylin and eosin.
Ovarian renin content and plasma renin A separate group of rats was used to estimate ovarian renin content and plasma renin. The right ovary from each rat was collected in 300 µl of 0·1 M PBS (pH 7·4) and snap-frozen in liquid N 2 for analysis of total renin content using established techniques (Berka et al. 1995 , Kelly et al. 1998 , Wilkinson-Berka et al. 2001 . The left ovary was collected in 300 µl of 0·1 M PBS (pH 7·4) with protease inhibitors (7·5 mM N-ethylmaleimide, 6 mM disodium ethylenediamine tetraacetic acid and 30 mM benzamidine) and snap-frozen in liquid N 2 for analysis of active renin content. Ovaries were stored at 20 C until the day prior to assay, when they were thawed, manually homogenised and refrozen overnight. Blood was collected from the tail vein of conscious animals into a heparinised tube (CSL, Parkville, Victoria, Australia) and subsequently centrifuged at 2000 g for 15 min and plasma was frozen in aliquots at 20 C until analysis.
The renin content of ovaries and plasma wasanalysed using an 125 I-labelled ANG I enzyme kinetic radioimmunoassay performed as described previously (Moravski et al. 2000 . Samples were incubated in duplicate (37 C for 0·5-3 h, pH 7·4) in the presence of inhibitors with 24 h nephrectomised rat plasma angiotensinogen substrate (reaction rate, 70% maximum velocity). Following the addition of buffered anti-ANG I antiserum (50% optimum binding capacity) and 125 I-labelled ANG I tracer (5000 c.p.m./ml, Austin Biomedical Services, Malvern, Victoria, Australia), the ANG I produced was estimated from an ANG I standard curve (10-1000 fmol ANG I). The renin present in each of the samples was estimated by comparison to the amount of ANG I generated by 2 10 6 Goldblatt units (GU) of hog renin (National Standards Laboratory, Holly Hill, London, UK). Tissue values were adjusted based on the initial volume the sample was collected in and normalised for tissue weight. Total renin was determined in samples following activation of prorenin with trypsin (6 mg/ml in 1 mM HCl at 4 C for 10 min, reaction stopped with 8 mg/ml soybean trypsin inhibitor), prior to the commencement of the assay. Prorenin was derived as total minus active renin (samples collected in protease inhibitors).
The effect of ANG II on follicle number and litter size
Comparisons were made between HTZ and HMZ (mRen-2)27 rats that display amplification of the circulating and extra-renal RAS, control SD rats and SD rats infused with ANG II.
Follicle identification and quantification Using serial sections of ovary collected for in situ hybridisation and immunohistochemistry (see above), every tenth section was stained with haematoxylin and eosin and the number of follicles counted in two randomly chosen sections. This method, which counts approximately 1% of serial sections, has previously been reported to be comparable to counting 10% of non-random sections of ovary in mice (Bucci et al. 1997) . Low-power images encompassing the entire section were captured using a Spot Digital Camera (SciTech Pty Ltd, Victoria, Australia) attached to an Olympus BH-2 Light Microscope (Olympus, Japan). Images were examined using ImagePro Plus software (v. 4.0.0.13; Media Cybernetics L.P., Singapore) and follicle diameter (in µm) measured on a calibrated system. Follicle diameter was determined as the average of the distance of the longest follicle axis and the length of the perpendicular axis. Follicles were classified into one of five size groups; primary (,80 µm), pre-antral (80-150 µm), antral (150-390 µm), large antral (390-500 µm) or preovulatory (.500 µm) (Hirshfield & Midgley 1978) . A follicle was considered to be undergoing atresia when a minimum of two pyknotic granulosa cells was observed in the cross-section of a follicle (Hirshfield & Midgley 1978) , or if they contained an abnormal-shaped oocyte or the granulosa cells were not regularly apposed with the basal lamina (Wulff et al. 2001) . Analysis was completed with the observer masked to all groups. Data were represented as a percentage of a follicle type when compared with the number of follicles per section.
Litter size The number of pups born to SD dams crossed with SD males, and HMZ dams crossed with HMZ males was determined (n=15 pups per strain). The number of HTZ (mRen-2)27 pups was not recorded as they are not derived from transgenic (mRen-2)27 mothers but from matings of female SD rats with male transgenic (mRen-2)27 rats. As the ANG II infusion study was performed in non-pregnant adult SD rats, the effect of ANG II on litter size in these animals could not be evaluated.
Verification that ANG II infusion in SD rats perturbs the circulating and ovarian RAS This was done in two ways: (i) evaluation of angiotensin receptor gene expression in the ovary using in situ hybridisation (see aim 1 of the study) and (ii) evaluation of the circulating and ovarian renin levels using an enzyme kinetic renin assay (see aim 1).
Statistical analysis
Statistical computations were performed using the commercially available statistics package SPSS (version 9.0; SPSS Inc., Chicago, IL, USA). Results are expressed as means S.E.M. Data were analysed using ANOVA when there were three or more groups with post-hoc analysis between groups made using Fisher's multiple comparisons test. Statistical comparison of data between two groups was made using a t-test for independent samples. Analysis of differences between two variables measured in the same group was made using a t-test for paired samples. A P value less than 0·05 was considered statistically significant.
Results
Systolic blood pressure
SBP was significantly higher in HMZ (mRen-2)27 rats (234 5 mmHg, n=8) compared with HTZ (mRen-2)27 rats (171 3 mmHg, n=8; P,0·001). Both HTZ and HMZ (mRen-2)27 rats displayed higher SBP than control SD rats (126 1 mmHg, n=8; P,0·001). SD rats treated with ANG II exhibited increased blood pressure (183·2 9·5 mmHg, n=8; P,0·001) compared with untreated SD rats that was similar to HTZ (mRen-2)27 rats but less than HMZ (mRen-2)27 rats (P,0·005).
The cellular location of RAS components in the rat ovary
These results are summarised in Table 1 .
Renin gene expression and immunolabelling
Renin mRNA was not detected in ovaries from control SD rats (Fig. 1A) . In HTZ and HMZ (mRen-2)27 rats, renin mRNA was present in the stroma (Fig. 1B) , in the theca of nearly all follicles (Fig. 1B) and in the thick granulosa layer of some large antral follicles (not shown). In all (mRen-2)27 rats, renin gene expression was not observed in corpora lutea. Quantification revealed the intensity of renin mRNA to be higher in ovaries of HMZ (mRen-2)27 rats compared with HTZ (mRen-2)27 rats and to be virtually undetected in control SD rats (Fig. 1) .
In control SD rats and (mRen-2)27 rats, renin protein immunolabelling was identified in cells and some blood vessels of corpora lutea (Fig. 1C) and to a lesser extent in the ovarian stroma (not shown). Renin protein immunolabelling appeared more intense in HTZ (mRen-2)27 (Fig. 1D) and HMZ (mRen-2)27 rat ovary compared with control SD rats (Fig. 1C) .
Angiotensin receptor gene expression
AT 1a mRNA was primarily located on clusters of small blood vessels in the ovarian stroma and adjacent to corpora lutea and large follicles ( Fig. 2A and B) . The abundance of AT 1a receptor mRNA in whole ovary was highest in control SD rats followed by HTZ and then HMZ (mRen-2)27 rats, a finding confirmed by densitometric analysis (Fig. 2) . AT 2 mRNA was localised to the granulosa layer of small-to medium-sized antral follicles exhibiting signs of atresia in both (mRen-2)27 and SD ovaries ( Fig. 2E-H) . AT 2 receptor mRNA at these sites was lower in HMZ (mRen-2)27 ovaries when compared with control SD and HTZ (mRen-2)27 rats (Fig. 2) . No differences were observed between control SD and HTZ (mRen-2)27 rats in the distribution or intensity of AT 2 receptor mRNA (Fig. 2) . Verification that ANG II infused into SD rats altered the ovarian RAS was shown by reduced AT 1a receptor mRNA compared with control SD rats (Fig. 2D) . Gene expression for the AT 2 receptor was unchanged following ANG II infusion in SD rats compared with control SD rats (Fig. 2H) .
Angiotensin II immunolabelling
In all rat strains, ANG II was localised to the ovarian stroma and its blood vessels (Fig. 3A-C) , atretic follicles ( Fig. 3D-F) , corpus luteum cells and blood vessels (Fig. 3G-I ) and granulosa cells particularly at the antral edge of some follicles (not shown). ANG II and corresponding dark field (a) of control SD ovary, renin gene expression is not observed; bright field (B) and corresponding dark field (b) of HTZ (mRen-2)27 ovary, renin gene expression localised to the stroma (double arrow) and theca (arrow), *P,0·0001 compared with all (mRen-2)27 rats, †P,0·05 compared with HTZ (mRen-2)27 rats. Renin protein immunolabelling: intense immunolabelling appears in corpus luteum cells (arrow) and blood vessels (double arrow) of control SD (C) and HTZ (mRen-2)27 (D) rats. (D-f) Magnification 300; scale bar, 100 m; counterstain, haematoxylin and eosin. S, stroma; F, follicle; Ren-2, transgenic (mRen-2)27 rat. AT 1a receptor mRNA in stroma (arrows) of control SD (A and a), HTZ (mRen-2)27 (B and b), HMZ (mRen-2)27 (C and c) and SD+ANG II (D and d) ovary: hybridisation is more intense in SD and HTZ (mRen-2)27 ovaries compared with other groups. AT 2 receptor mRNA in granulosa cell layer of atretic follicles (arrows) of control SD (E and e), HTZ (mRen-2)27 (F and f) and HMZ (mRen-2)27 (G and g) and SD+ANG II (H and h) ovary: hybridisation is intense in all groups except HMZ (mRen-2)27. Graphical data are presented as means S.E.M.; n=6 rats per group. For the AT 1a receptor: *P,0·05 compared with control SD; # P,0·0001 compared with control SD; †P,0·05 compared with HMZ (mRen-2)27. For the AT 2 receptor: *P,0·0001 compared with HMZ (mRen-2)27; #P,0·05 compared with HMZ (mRen-2)27.
immunolabelling appeared most intense in ovaries of HMZ (mRen-2)27 rats followed by HTZ (mRen-2)27 and then control SD rats.
Angiotensinogen immunolabelling
The distribution and intensity of angiotensinogen immunolabelling was similar in control SD, HTZ (mRen-2)27 and HMZ (mRen-2)27 ovaries ( Fig. 3J-M) . Angiotensinogen immunolabelling was prominent in the granulosa layer of developing follicles, particularly in cells adjacent to the follicular fluid, the follicular fluid itself and the cumulus oophorus ( Fig. 3J and K) . Labelling was also observed in some blood vessels in corpora lutea (Fig. 3L  and M) , in the germinal epithelium and in some scattered stromal cells (Fig. 3J and K) .
ACE autoradiography
125 I-labelled MK-351A binding to cellular ACE appeared to be more intense in the ovaries of HTZ (mRen-2)27 rats compared with control SD rats ( Fig. 4A and E) . HMZ (mRen-2)27 rats were not studied. Light microscopy examination of emulsion autoradiography revealed ACE ligand binding (Fig. 4C, D , G and H) to be located in the ovarian stroma including blood vessels, on the germinal epithelium, in the cell layer surrounding corpora lutea and on some follicles. Quantification of the density of 125 I-labelled MK-351A binding to cellular ACE in whole ovary was significantly higher (P,0·05) in HTZ (mRen-2)27 rats (61·9 0·5 ROD, mean S.E.M.) compared with SD ovaries (59·1 0·8 ROD, mean S.E.M.). Non-specific binding was negligible in all sections ( Fig. 4B  and F) .
Plasma renin and ovarian renin content
Plasma renin As expected for (mRen-2)27 rats with overexpression of the extra-renal RAS (Mullins et al. 1990) , plasma renin was predominately prorenin (Fig. 5A) . Plasma prorenin was highest in HMZ (mRen-2)27 rats followed by HTZ (mRen-2)27 rats and then control SD rats and SD rats infused with ANG II. In control SD rats, plasma renin was mainly in an active form (Fig. 5A) . Plasma active renin was highest in control SD rats followed by HMZ (mRen-2)27 rats, HTZ (mRen-2)27 rats and then SD rats infused with ANG II. The infusion of ANG II into SD rats reduced plasma active renin.
Ovarian renin content In all rats, ovarian renin was mainly in an active form. Ovarian active renin was highest in HMZ (mRen-2)27 rats, followed by HTZ (mRen-2)27 rats, control SD rats and then SD rats infused with ANG II. In SD rats, ovarian active renin content was reduced with ANG II infusion. Ovarian prorenin was similar between all groups except for HTZ (mRen-2)27 rats where ovarian prorenin content was less than in SD rats infused with ANG II.
Litter size
Fewer pups per litter were born to HMZ (mRen-2)27 rats (8·7 0·7) than control SD rats (13·0 0·4), P,0·05.
Follicle quantification
At proestrus, all groups had similar numbers of primary follicles (control SD, 18·4 5·1; HTZ (mRen-2)27, 10·4 3·9; HMZ (mRen-2)27, 11·1 2·3; SD+ANG II, 21·2 3·9). Pre-antral follicles were more abundant in HMZ (mRen-2)27 rats compared with all other groups (control SD, 19·4 2·9; HTZ (mRen-2)27, 24·2 1·1; HMZ (mRen-2)27, 33·8 3·3; SD+ANG II, 23·6 2·4; P,0·05). The number of antral follicles was similar between all groups (control SD, 37·5 4·5; HTZ (mRen-2)27, 53·4 3·8; HMZ (mRen-2)27, 48·3 4·9; SD+ANG II, 48·5 5·5). Compared with control SD rats, fewer large antral and preovulatory follicles were observed in HTZ (mRen-2)27, HMZ (mRen-2)27 and SD rats infused with ANG II (Fig. 6) .
Discussion
The present study has localised components of the RAS to three distinct compartments within the rat ovary, namely the stroma, follicles (mainly atretic) and to a lesser extent corpora lutea. The presence of angiotensin receptors within the stroma and atretic follicles indicates that the RAS at these sites is likely to have a functional role. In general, components of the RAS were in the same location but more abundant in transgenic (mRen-2)27 rats compared with SD rats, highlighting the usefulness of the (mRen-2)27 rat, with its enhanced extra-renal RAS, for detecting and studying the ovarian RAS. The increased expression of the ovarian RAS in (mRen-2)27 rats was counterstain, haematoxylin. S, stroma; F, follicle; GE, germinal epithelium; Ren-2, transgenic (mRen-2)27 rat. ANG II immunolabelling: in stroma (A, B and C), immunolabelling is observed in blood vessels (arrow) and stromal cells; in atretic follicles (D, E and F), immunolabelling is observed in granulosa cells (arrow), asterisk indicates pyknotic nuclei; in corpora luteum (G, H and I), immunolabelling is in corpus luteum cells (arrow). Angiotensinogen immunolabelling: in follicles (J and K), immunolabelling is located in the granulosa layer (arrow) and cumulus oophorus (asterisk); in corpora luteum (L and M), immunolabelling is on blood vessels (double arrow). associated with both reduced litter size and numbers of large antral and preovulatory follicles. A similar situation was found in SD rats infused with ANG II, indicating that increased ANG II may influence follicular development.
Considerable species differences exist with regard to the distribution and relative abundance of components of the RAS in the ovary. Previous studies in the rat have identified RAS components in various areas of the ovary (Kim et al. 1987 , Daud et al. 1990 , Thomas & Sernia 1990 , Obermuller et al. 1998 ), but to our knowledge none have provided a consistent survey of the ovarian RAS in the rat in situ. The present study identified a discrete RAS within the ovarian stroma and its blood vessels, including renin gene expression, angiotensinogen and ANG II protein and ACE binding. Of particular importance when attributing a function to the stromal RAS, is the localisation of AT 1a receptor mRNA to the stroma adjacent to large follicles and corpora lutea, a finding previously reported in the bovine ovary (Schauser et al. 2001) . The AT 1a receptor is viewed to elicit most of the cell growth and angiogenic properties of ANG II (Chung et al. 1998) , and it is therefore likely that ANG II at this site influences processes such as blood flow, vascularisation and growth of developing follicles via this receptor. The finding that AT 1a receptor expression is reduced in HMZ (mRen-2)27 rats may be a result of the elevated ANG II in this strain compared with HTZ (mRen-2)27 and SD rats. This is supported by our finding that ovarian AT 1a receptor mRNA is reduced in SD rats infused with ANG II, and by previous reports where high ANG II downregulates ANG II receptors in rat cultured granulosa cells (Pucell et al. 1988) and aortic vascular smooth muscle cells (Lassegue et al. 1995) .
Figure 5
Plasma renin (A) and ovarian renin content (B) in SD rats and HTZ and HMZ (mRen-2)27 rats at proestrus. Data are presented as means S.E.M.; n=6 rats per group. GU, Goldblatt units; Ren-2, transgenic (mRen-2)27 rat. (A) Plasma; *P,0·001 compared with respective active renin; #P,0·005 compared with respective prorenin. Prorenin: a, P,0·0001 compared with all groups; b, P,0·05 compared with control SD and P,0·01 compared with SD+ANG II. Active renin: c, P,0·0001 compared with all groups; d, P,0·005 compared with HTZ (mRen-2)27 rats; e, P,0·001 compared with all (mRen-2)27 rats. (B) Ovarian renin content; *P,0·0001 compared with respective prorenin; #P,0·005 compared with respective prorenin. Prorenin: a, P,0·05 compared with SD+ANG II. Active renin: b, P,0·0001 compared with all groups; c, P,0·005 compared with SD and P,0·0001 compared with SD+ANG II; d, P,0·05 compared with SD+ANG II.
Figure 6
The number of large antral (A) and pre-ovulatory (B) follicles in 3 m sections of ovary from control SD rats, HTZ and HMZ transgenic (mRen-2)27 rats and SD rats infused with ANG II. Data are presented as means S.E.M.; n=6 rats per group. Ren-2, transgenic (mRen-2)27 rat. (A) Large antral follicles: *P,.005 compared with all groups. (B) Pre-ovulatory follicles: *P,0·01 compared with control SD rats; #P,0·0005 compared with control SD rats; †P,0·0001 compared with control SD rats.
Most of the components of the RAS were also localised to atretic follicles in both SD and transgenic (mRen-2)27 rats, suggesting that a distinct system may also exist within these follicles. The reason for the absence of renin protein immunolabelling in atretic follicles despite the presence of renin mRNA is unclear, but may indicate a translational modification in these follicles. Our finding that AT 2 but not AT 1a receptor gene expression is located in atretic follicles is consistent with previous studies in rats (Tanaka et al. 1995 , Obermuller et al. 1998 , where the AT 2 receptor was found to predominate in granulosa cells of follicles entering into atresia. This is consistent with the view that the AT 2 receptor mediates apoptosis in some situations and opposes the proliferative effects of the AT 1 receptor (Yamada et al. 1996 , Chung et al. 1998 .
It is well known that ANG II modulates ovarian steroidogenesis and corpora lutea formation (Yoshimura 1997 , Speth et al. 1999 , Vinson et al. 1999 . In the present study, renin, ANG II and angiotensinogen immunolabelling and ACE binding were detected in both SD and (mRen-2)27 rat corpora lutea. A similar distribution for these RAS components has been reported previously in the rat (Lightman et al. 1988 , Palumbo et al. 1989 and also in human (Palumbo et al. 1993 ) and bovine (Hayashi et al. 2000 , Kobayashi et al. 2001 ovaries. Despite this evidence that some of the components of the RAS are located in corpora lutea, we were unable to detect either renin or angiotensin receptor gene expression, suggesting that renin and ANG II in corpora lutea may be sequestered from blood vessels or neighbouring cells. Previous studies in the rat have also reported angiotensin receptors to be absent in corpora lutea (Obermuller et al. 1998) , while other studies have reported angiotensin receptors in cultured luteal cells (Pepperell et al. 1993) and renin mRNA in corpora lutea following gonadotrophin stimulation (Lightman et al. 1987) . In other species the results are also inconsistent with angiotensin receptors reported to be both present (Hayashi et al. 2000 , Schams et al. 2003 and absent (Schauser et al. 2001) in corpora lutea from cows and in low levels in pigs (Nielsen et al. 1995) . The reason for the discrepancies between the studies is unclear but may relate to species variations and/or modulation of the RAS by gonadotrophins at various stages of the oestrus cycle (Loret de Mola et al. 1999) .
In the present study, the degree of Ren-2 gene expression in (mRen-2)27 rats was associated with the abundance of the ovarian and circulating RAS. Transgenic (mRen-2)27 rats homozygous for the Ren-2 gene had higher expression of the ovarian RAS components and higher plasma prorenin and ovarian active renin levels than HTZ (mRen-2)27 rats. Of interest was that overexpression of the ovarian RAS in (mRen-2)27 rats was associated with a reduction in the number of large antral and preovulatory follicles and litter size, and this was most obvious in HMZ (mRen-2)27 rats. It would therefore seem reasonable to argue that increased renin and angiotensin in the ovary influences multiple processes within the ovary including follicular development, ovulation and subsequently birth rate. To further assess this concept, SD rats were infused with ANG II. The response of circulating and tissue RASs to ANG II infusion was verified by the observed reduction in active renin, which is expected as increased ANG II reduces renin production via a negative feedback mechanism. In addition, the infusion of ANG II into SD rats induced a similar reduction in large antral and preovulatory follicles as observed in HMZ (mRen-2)27 rats. The finding that ANG II infusion in SD rats reduced AT 1a receptors in the stroma but had no effect on AT 2 mRNA, indicates that the reduction in large antral and preovulatory follicles may have resulted from ANG II via the AT 1a receptor modulating processes (such as blood flow, vascularisation and cell growth in the stroma) which are necessary for follicular growth. Furthermore, concentration-dependent effects of ANG II on oocyte viability have also been reported in rabbit ovaries perfused in vivo (Kuo et al. 1991) , and this may partially explain why preovulatory follicles were found in fewer numbers in HMZ compared with HTZ (mRen-2)27 rats. A reason for the reduced litter size in homozygous (mRen-2)27 rats may be the known effects of ANG II on ovulation (Pellicer et al. 1988 , Daud et al. 1990 , Peterson et al. 1993 . For instance, in mice with an enhanced ovarian RAS, a dose-dependent increase in expression of the angiotensinogen gene is associated with a reduction in ovulation rate (Hefler & Gregg 2001) . The reduction in large antral and preovulatory follicles described in the present study may also be explained by enhanced follicular apoptosis via the AT 2 receptor. In cultured hamster follicles, ANG II treatment reduces the oestradiol to androgen ratio resulting in morphological changes in the theca interna that are observed in follicular atresia (Kitzman & Hutz 1992) . These findings are supported by the studies of Kotani et al. (1999) who reported in cultured rat granulosa cells that AT 2 content increases in a time-dependent manner and parallels the progression of atresia.
The hypertension of the (mRen-2)27 rat and SD rats infused with ANG II may have also influenced follicular development and litter size. Vasoconstriction of ovarian vessels may alter follicular growth by compromising vessel patency, which is necessary for antral formation and enlargement and ovulation (Tsafriri 1995) . Although the effect of hypertension on follicular development was not directly examined, our previous studies in the diabetic (mRen-2)27 rat indicate that amplification of the tissue RAS affects cell growth in the kidney and retina by a blood pressure independent mechanism (Kelly et al. 1998 , Moravski et al. 2003 . Further studies are required to determine if a similar effect occurs in the (mRen-2)27 rat ovary.
In summary, overexpression of the ovarian RAS in the transgenic (mRen-2)27 rat facilitated the characterisation of the tissue RAS in the stroma, atretic follicles and corpora lutea of the ovary. The localisation of AT 1a receptors to healthy follicles and AT 2 receptors to atretic follicles suggests that these receptors play a differential role in balancing normal folliculogenesis. Increased expression of the RAS in the (mRen-2)27 rat or by ANG II infusion in SD rats perturbs this balance resulting in a reduction in large antral and preovulatory follicles, and ultimately birth rate. Whether pharmacological blockade of the AT 1 or AT 2 receptors confers differential effects on folliculogenesis and atresia is not fully known, but such studies are warranted to further understand the role of the ovarian RAS in the normal ovary and pathologies such as polycystic ovary syndrome where overactivity of the circulating and ovarian RAS occurs (Yoshimura 1997) .
